Conformation-X Therapeutics is an immune-oncology focused drug development company.
Conformation-X Therapeutics has raised $3.6M in total funding. The most recent round was Seed. The last funding was announced in April 2024.
Conformation-X Therapeutics is headquartered in Canton, United States.
Conformation-X Therapeutics is an immune-oncology focused drug development company.
Conformation-X Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Conformation-X Therapeutics — Funding & Investors." VCBacked, April 3, 2024, https://www.vcbacked.co/company/conformation-x-therapeutics. Accessed August 15, 2026.
VCBacked. (2024). Conformation-X Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/conformation-x-therapeutics
{{cite web |title=Conformation-X Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/conformation-x-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated